RDY

#839
Dr. Reddy's Laboratories Limited American Depositary Shares
13.26 USD
+0.15%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
13.26
13.28
Годовой диапазон
12.81
16.16
Дневное изменение
+0.15%
Месячное изменение
-5.35%
6-месячное изменение
-5.08%
Годовое изменение
-0.60%
Предыдущее закрытие
13.24
Открыть
13.26
Bid
Ask
Минимум
13.26
High
13.28
Объем
89
Открыть полный график

Financials

Обзор Отчетность Статистика Дивиденды
Квартал Год
  • Market Capitalization 11.06 B
  • Employee 28 K
  • Founded 1984
  • CEO Erez Israeli
  • Website www.drreddys.com
  • Headquarter India
  • FIGI BBG000NJ96L6
  • Industry Technology
Общий доход
Чистая прибыль
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты

Dr. Reddy's Laboratories Ltd

Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr.

Новости